The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients

BACKGROUND: We analyzed the efficacy and toxicity of cabazitaxel (CBZ) at high and low initial doses in Japanese patients with docetaxel-resistant castration-resistant prostate cancer (CRPC). METHODS: We retrospectively evaluated 118 patients who received CBZ for docetaxel-resistant CRPC in 10 unive...

Descripción completa

Detalles Bibliográficos
Autores principales: Terada, Naoki, Kamoto, Toshiyuki, Tsukino, Hiromasa, Mukai, Shoichiro, Akamatsu, Shusuke, Inoue, Takahiro, Ogawa, Osamu, Narita, Shintaro, Habuchi, Tomonori, Yamashita, Shinichi, Mitsuzuka, Koji, Arai, Yoichi, Kandori, Shuya, Kojima, Takahiro, Nishiyama, Hiroyuki, Kawamura, Yoshiaki, Shimizu, Yuki, Terachi, Toshiro, Sugi, Motohiko, Kinoshita, Hidefumi, Matsuda, Tadashi, Yamada, Yusuke, Yamamoto, Shingo, Hirama, Hiromi, Sugimoto, Mikio, Kakehi, Yoshiyuki, Sakurai, Toshihiko, Tsuchiya, Norihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377784/
https://www.ncbi.nlm.nih.gov/pubmed/30770773
http://dx.doi.org/10.1186/s12885-019-5342-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377784/
https://www.ncbi.nlm.nih.gov/pubmed/30770773
http://dx.doi.org/10.1186/s12885-019-5342-9

Ejemplares similares